Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Nurix Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +12 vs. Q3 2021
- Shares held
- 40.4M
- +946.2K (+2.4%) vs. Q3 2021
- Total value
- $1.17B
- −$13.9M (−1.2%) vs. Q3 2021
- New holders
- 24
- 43 more added
- Sold out
- 12
- 36 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $2.84B |
| Q1 2026 | 196 | $1.81B |
| Q4 2025 | 182 | $2.15B |
| Q3 2025 | 173 | $783.3M |
| Q2 2025 | 164 | $1.01B |
| Q1 2025 | 170 | $1.01B |
| Q4 2024 | 175 | $1.53B |
| Q3 2024 | 172 | $1.53B |
| Q2 2024 | 174 | $1.36B |
| Q1 2024 | 139 | $721.3M |
| Q4 2023 | 131 | $475.6M |
| Q3 2023 | 129 | $352.5M |
| Q2 2023 | 126 | $435.7M |
| Q1 2023 | 124 | $376.6M |
| Q4 2022 | 119 | $468.6M |
| Q3 2022 | 118 | $561.0M |
| Q2 2022 | 106 | $568.4M |
| Q1 2022 | 117 | $565.6M |
| Q4 2021 | 125 | $1.17B |
| Q3 2021 | 113 | $1.18B |
| Q2 2021 | 104 | $1.05B |
| Q1 2021 | 101 | $1.29B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 321,050 | $9.29M | 0.21% | +2,600+0.8% | Added |
| Ponoi Management, LLC | 327,122 | $9.47M | 8.73% | −234,451−41.7% | Reduced |
| Ponoi II Management, LLC | 327,123 | $9.47M | 17.20% | −234,451−41.7% | Reduced |
| Clough Capital Partners L P | 473,048 | $13.7M | 0.92% | 00.0% | Unchanged |
| Woodline Partners LP | 592,941 | $17.2M | 0.25% | +455,540+331.5% | Added |
| Millennium Management LLC | 596,286 | $17.3M | 0.02% | +359,403+151.7% | Added |
| Geode Capital Management, LLC | 621,547 | $18.0M | 0.00% | −9,151−1.5% | Reduced |
| Soleus Capital Management, L.P. | 743,238 | $21.5M | 2.90% | +479,338+181.6% | Added |
| Candriam Luxembourg S.C.A. | 794,103 | $23.0M | 0.15% | +239,107+43.1% | Added |
| Jennison Associates LLC | 911,004 | $26.4M | 0.02% | −8,215−0.9% | Reduced |
| FMR LLC | 1,108,103 | $32.1M | 0.00% | +449,486+68.2% | Added |
| Pictet Asset Management SA | 1,121,935 | $32.5M | 0.03% | +194,385+21.0% | Added |
| Wellington Management Group LLP | 1,162,316 | $33.6M | 0.01% | −63,742−5.2% | Reduced |
| Wasatch Advisors Inc | 1,203,589 | $34.8M | 0.14% | +31,932+2.7% | Added |
| Foresite Capital Management IV, LLC | 1,205,798 | $34.9M | 7.18% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,224,892 | $35.5M | 1.41% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 1,284,313 | $37.2M | 2.95% | −10.0% | Reduced |
| State Street Corp | 1,557,712 | $45.1M | 0.00% | −75,419−4.6% | Reduced |
| Eventide Asset Management, LLC | 1,870,000 | $54.1M | 0.69% | +670,000+55.8% | Added |
| Vanguard Group Inc | 1,990,564 | $57.6M | 0.00% | +12,613+0.6% | Added |
| TRV GP III, LLC | 2,422,549 | $70.1M | 17.55% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,454,082 | $71.0M | 0.35% | 00.0% | Unchanged |
| BlackRock Inc. | 2,547,861 | $73.8M | 0.00% | +64,288+2.6% | Added |
| Redmile Group, LLC | 2,958,284 | $85.6M | 1.95% | −134,793−4.4% | Reduced |
| Price T Rowe Associates Inc | 4,871,084 | $141.0M | 0.01% | +152,207+3.2% | Added |
| Foresite Capital Management V, LLC | 0 | $0 | 0.00% | −451,522−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −164,255−100.0% | Sold out |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −39,762−100.0% | Sold out |
| Mission Creek Capital Partners, Inc. | 0 | $0 | 0.00% | −39,764−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −19,085−100.0% | Sold out |
| Mass General Brigham, Inc | 0 | $0 | 0.00% | −15,904−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −10,747−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −10,546−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −8,617−100.0% | Sold out |
| Grace Capital | 0 | $0 | 0.00% | −6,727−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,015−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −299−100.0% | Sold out |